GE HealthCare has launched Invenia ABUS (Automated Breast Ultrasound) Prime, along with ABUS StreamVue, an enterprise viewer that has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the CE Mark.
The system expands the company's breast imaging portfolio with tools for supplemental screening of women with dense breasts and remote exam review, GE HealthCare said. Invenia ABUS Prime features cSound Imageformer with AI-enabled tools for scan quality assessment and nipple detection, a Fast Scan tool that increases scan speed by up to 40%, and AI-supported reading powered by QVCAD, which the company said has demonstrated a 33% reduction in reading time and up to 93% sensitivity for lesion detection. Invenia ABUS Prime has received U.S. Food and Drug Administration premarket approval and CE Marking.
ABUS StreamVue is a browser-based reading solution designed to enable remote exam review across enterprise imaging networks, according to the company. GE HealthCare is collaborating with Candelis on the technology.
Among the first U.S. installations of Invenia ABUS Prime is at BeSound in Los Angeles, the company said.
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
